Blockade of neonatal activation of the pituitary-testicular axis: effect on peripubertal luteinizing hormone and testosterone secretion and on testicular development in male monkeys

The Journal of Clinical Endocrinology and Metabolism
D R MannKim Wallen

Abstract

The objective of this study was to examine the effect of blockade of neonatal activation of the pituitary-testicular axis, using a GnRH agonist, on sexual development in male rhesus monkeys. Monkeys were treated with either a GnRH agonist (10 micrograms/day; n = 8) or vehicle (n = 9) for 112 days using osmotic minipumps beginning at 10-13 days of age. In control monkeys serum LH and testosterone concentrations during the first 3 postnatal months were similar to those in adults; they then declined to very low levels. GnRH agonist administration caused an immediate and precipitous decline in serum LH and testosterone concentrations to very low levels, and both remained low throughout the rest of the agonist administration period. Neither group had any significant elevation in serum LH or testosterone concentrations during the next 2 yr. In the control monkeys serum LH and testosterone began to rise during the third year, with a rapid increase occurring during the fall coincident with the breeding season. This peripubertal rise of LH and testosterone secretion was associated with rapid enlargement of the testes and the appearance of sperm in ejaculates. The monkeys who had received GnRH agonist had subnormal serum LH and testoster...Continue Reading

Citations

Aug 1, 1995·Physiology & Behavior·F B Bercovitch, A S Clarke
Jun 1, 1995·The Journal of Steroid Biochemistry and Molecular Biology·M A RivarolaM T de Dávila
Jun 21, 2002·European Urology·F Hadziselimovic
Oct 12, 1999·American Journal of Reproductive Immunology : AJRI·D R MannH M Fraser
Sep 22, 2000·Archives of Disease in Childhood·P I Hughes
Jun 15, 2000·Environmental Health Perspectives·J L PryorB Robaire
Dec 13, 2006·Best Practice & Research. Clinical Endocrinology & Metabolism·Ieuan A Hughes, Asma Deeb
Nov 7, 2006·Early Human Development·Rebecca Christine Knickmeyer, Simon Baron-Cohen
Jun 29, 1999·Baillière's Clinical Endocrinology and Metabolism·P L Whitten, F Naftolin
Nov 5, 2013·General and Comparative Endocrinology·Katharine M JackLinda Fedigan
Nov 20, 2012·Psychoneuroendocrinology·Jessica RaperMar Sanchez
Nov 18, 2014·Frontiers in Endocrinology·Kai XiaRebecca C Knickmeyer
Sep 29, 2006·Journal of Child Neurology·Rebecca Christine Knickmeyer, Simon Baron-Cohen
Sep 16, 2005·American Journal of Primatology·Laurence R GesquiereEmmanuel O Wango
Sep 30, 2005·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Ling-Hong LiMari S Golub
Oct 26, 1999·Endocrine Reviews·J D Wilson
Aug 2, 2019·Molecular Reproduction and Development·Indrashis BhattacharyaSubeer S Majumdar
Feb 19, 1998·The Journal of Clinical Endocrinology and Metabolism·A M AnderssonN E Skakkebaek
Oct 25, 2017·Birth Defects Research·Catherine A PicutD Stanislaus
Jul 14, 2004·Molecular and Cellular Endocrinology·Mala MahendrooRichard J Auchus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.